Cite
APA Citation
Halota, W., Ferenci, P., Kozielewicz, D., Dybowska, D., Lisovoder, N., Samira, S., Shalit, I., Ellis, R., & Ilan, Y. (2015). oral anti‐CD3 immunotherapy for HCV‐nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase‐2a placebo‐controlled trial. Journal of viral hepatitis, 22(8), 651–657. http://access.bl.uk/ark:/81055/vdc_100025953675.0x000022